101 results
Page 3 of 6
8-K
kglmzb8f1tcrlim2mk
25 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
EX-99.1
ffw5yxfb 1d4w
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
424B5
2k7rca7e0us0x0
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
80dse2gizwy3qzvy
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
kbl33qv
10 Nov 21
Prospectus supplement for primary offering
5:25pm
424B5
tzylb617
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
1pigfv4nh
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
EX-99.1
2uvgl4 5ubal8v9lesjf
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
8-K
EX-99.1
cpj163 q04e
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
8-K
EX-99.1
z5vadnmt
14 Aug 20
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
8:30am